Key papers ✓ 5✗ 2~ 1

• ✓ Positive systematic reviewCochrane Database Syst Rev · 2018

  Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency.

  Humans153 people3 RCTs pooled3 to 4 months of treatment and follow-up

  Cochrane systematic review of RCTs (no meta-analysis)

  Cochrane review of 3 RCTs (153 people): oral and intramuscular B12 normalised blood B12 similarly in deficiency (low-quality evidence), with oral treatment costing less.

  Key resultAt 1000 μg/day oral, no clinically relevant difference in B12 levels vs IM; one trial at 2000 μg/day showed a mean difference of 680 pg/mL (95% CI 392.7 to 967.3) favouring oral

  Study details

  Studied

  People with vitamin B12 deficiency (mean age 38.6 to 72 years) in three RCTs

  Compared with

  Intramuscular vitamin B12

  Main outcome

  Serum vitamin B12 levels, symptoms, adverse events

  Sample

  3 RCTs, 153 participants (74 oral, 79 IM)

  Authors' conclusion

  Low-quality evidence shows oral and IM B12 have similar effects on normalising serum B12 and oral costs less; very low-quality evidence suggests oral is as safe.

  Limitations

  Only 3 small trials, low to very low-quality evidence; no trial reported clinical signs and symptoms.

  DOI 10.1002/14651858.CD004655.pub3PubMed 29543316Free full text
• ✓ Positive meta-analysisFront Pharmacol · 2025

  Efficacy of sublingual and oral vitamin B12 versus intramuscular administration: insights from a systematic review and meta-analysis.

  Humans6,098 people16 studies pooledRandomized trials

  Systematic review and random-effects meta-analysis (RCTs, cohort, case-control)

  Meta-analysis of 16 studies (6,098 participants): B12 raised blood cobalamin and lowered homocysteine, with no significant difference between oral, sublingual and injected routes.

  Key resultSerum cobalamin pooled mean difference +402.6 pg/mL (95% CI 293.6 to 511.5; p < 0.001); homocysteine -4.83 μmol/L (95% CI -6.55 to -3.11; p < 0.001); no difference between routes (p = 0.270 cobalamin)

  Study details

  Studied

  Participants in 16 studies of oral, sublingual or IM vitamin B12

  Compared with

  Intramuscular injection vs oral vs sublingual

  Main outcome

  Serum cobalamin and homocysteine

  Sample

  16 studies, 6,098 participants

  Authors' conclusion

  Sublingual and oral B12 appear as effective as IM injections in improving cobalamin status and reducing homocysteine; further high-quality RCTs are warranted.

  Limitations

  Substantial heterogeneity (I2 > 80%) and possible publication bias.

  DOI 10.3389/fphar.2025.1602976PubMed 41487531Free full text
  FIGURE 3 FIGURE 7
• ✓ Positive meta-analysisIr J Med Sci · 2024

  Efficacy of different routes of vitamin B12 supplementation for the treatment of patients with vitamin B12 deficiency: A systematic review and network meta-analysis.

  Humans4,275 people13 studies pooled

  Systematic review and frequentist network meta-analysis of comparative studies

  Network meta-analysis of 13 studies (4,275 patients): oral, sublingual and intramuscular B12 all raised B12 levels effectively, with no significant differences between routes.

  Key resultVersus oral, IM and SL raised B12 by MD 94.09 and 43.31 pg/mL respectively, not statistically significant

  Study details

  Studied

  Patients with vitamin B12 deficiency

  Compared with

  Oral vs intramuscular vs sublingual routes

  Main outcome

  Vitamin B12 level, hemoglobin, other CBC parameters, homocysteine

  Sample

  13 studies, 4275 patients

  Authors' conclusion

  IM, oral and SL routes can all effectively increase B12 without significant differences; IM ranked top statistically but without clinical significance.

  Limitations

  Differences non-significant owing to the limited number of studies.

  DOI 10.1007/s11845-023-03602-4PubMed 38231320Free full text
• ✓ Positive human RCTBlood · 1998

  Effective treatment of cobalamin deficiency with oral cobalamin.

  Humans38 peopleRandomized4 months (120 days oral)

  Randomized trial

  RCT in 38 B12-deficient patients: daily oral cyanocobalamin corrected blood and neurologic abnormalities as well as intramuscular injections and produced higher B12 levels at 4 months.

  Key resultAt 4 months, serum cobalamin 1,005 pg/mL oral vs 325 pg/mL parenteral (P < .0005); methylmalonic acid 169 vs 265 nmol/L (P < .05)

  Study details

  Studied

  Newly diagnosed cobalamin-deficient patients

  Compared with

  Cyanocobalamin 1 mg intramuscularly on a schedule

  Main outcome

  Hematologic and neurologic improvement; serum cobalamin, methylmalonic acid, homocysteine

  Sample

  38 patients randomized; 33 evaluable (18 oral, 15 parenteral)

  Authors' conclusion

  2 mg oral cyanocobalamin daily was as effective as 1 mg IM monthly and may be superior in cobalamin deficiency.

  Limitations

  Five patients excluded for folate deficiency, leaving 33 evaluable.

  PubMed 9694707
• ~ Mixed systematic reviewCureus · 2025

  The Neurological Sequelae of Vitamin B12 Deficiency: A Systematic Review and Randomized Controlled Trial.

  Humans10 RCTs10 RCTs pooled

  Systematic review of randomized controlled trials

  Review of 10 RCTs: supplementation improved neurological symptoms in overt deficiency, but not cognitive or neurological outcomes in older adults with subclinical deficiency.

  Study details

  Studied

  Individuals with clinical and subclinical vitamin B12 deficiency

  Main outcome

  Neurological and cognitive outcomes

  Authors' conclusion

  B12 supplementation is effective in clinical deficiency but shows limited neurological benefit in subclinical cases; oral therapy had similar efficacy to IM; further trials needed.

  Limitations

  Homocysteine reductions did not consistently correlate with clinical improvements; standardized outcomes lacking.

  DOI 10.7759/cureus.83668PubMed 40486314Free full text
• ✓ Positive human trialJ Gerontol A Biol Sci Med Sci · 2001

  Cobalamin supplementation improves cognitive and cerebral function in older, cobalamin-deficient persons.

  Humans16 peoplePlacebo-controlled6 months total

  Single-blind placebo-controlled intervention (1 month placebo then 5 months IM hydroxycobalamin)

  Single-blind study in 16 older adults with low B12: 5 months of hydroxocobalamin injections improved some verbal memory and fluency tests and EEG measures.

  Study details

  Studied

  Community-dwelling elderly with low plasma cobalamin and no cognitive impairment

  Compared with

  Preceding placebo month

  Main outcome

  Plasma Cbl, tHcy, MMA, qEEG, psychometric tests

  Sample

  16 healthy elderly subjects with low plasma cobalamin

  Authors' conclusion

  Cbl supplementation was followed by improved electrographic and cognitive function in older subjects with low plasma Cbl, related to reduced tHcy.

  Limitations

  Small, single-blind, no parallel control (placebo period preceded treatment).

  DOI 10.1093/gerona/56.12.m775PubMed 11723153
• ✗ Negative human RCTJAMA Otolaryngol Head Neck Surg · 2021

  Effect of Vitamin B12 Injection on the Vocal Performance of Professional Singers: A Randomized, Double-blind, Placebo-Controlled, Crossover Trial.

  Humans20 peopleRandomizedPlacebo-controlledDouble-blindOutcomes up to 1 week; washout at least 4 weeks

  Randomized, double-blind, placebo-controlled crossover trial

  Crossover RCT in 20 singers without B12 deficiency: a B12 injection did not improve vocal symptoms or fatigue more than a saline placebo.

  Key resultMedian difference between placebo and B12 at 72 hours was 1.5 (95% CI -2 to 5) for SVHI-10; improvements were comparable and below minimal clinically important difference

  Study details

  Studied

  Active adult singers (10 men, median age 22) without dysphonia but with mild vocal symptoms

  Compared with

  Saline placebo injection

  Main outcome

  Singing Voice Handicap Index-10 at 72 hours

  Sample

  20 singers, randomized crossover

  Authors' conclusion

  Empirical B12 injection did not produce a meaningful improvement in self-reported voice measures compared with placebo in singers.

  Limitations

  Small sample; participants not B12 deficient.

  DOI 10.1001/jamaoto.2020.4026PubMed 33180098Free full text
• ✗ Negative human RCTArch Intern Med · 1989

  Liver extract-folic acid-cyanocobalamin vs placebo for chronic fatigue syndrome.

  Humans15 peopleRandomizedPlacebo-controlledDouble-blind

  Double-blind placebo-controlled crossover trial

  Crossover RCT in 15 chronic fatigue syndrome patients: injections of liver extract with folic acid and cyanocobalamin were no better than placebo.

  Study details

  Studied

  Patients meeting CDC criteria for chronic fatigue syndrome

  Compared with

  Placebo

  Main outcome

  Functional status

  Sample

  15 chronic fatigue syndrome patients

  Authors' conclusion

  No significant difference between placebo and liver extract-folic acid-cyanocobalamin; the placebo response appeared strong.

  Limitations

  Small trial (15 patients); product combined liver extract, folic acid and cyanocobalamin.

  PubMed 2684076

Reported side effects

• reportedAcne-like skin eruption after injections [ref] [ref]
• reportedAnaphylaxis after intramuscular cyanocobalamin [ref]
• commonRed urine and skin reddening (high-dose IV hydroxocobalamin) [ref]
• reportedTemporary blood-pressure rise (high-dose IV hydroxocobalamin) [ref]

B12 is generally well tolerated; rare allergic reactions and acne-like eruptions are reported with injections, and the IV effects above come from gram-level antidote doses.

121 registered human trials (12 active)

✓ positive · ✗ negative · ~ mixed · ? inconclusive, judged on each paper's own main outcome. Grades: A strong human evidence → D little or none. Papers and verdicts are drawn from PubMed, Europe PMC and Russian journals (CyberLeninka); not medical advice.